New perspectives drive paradigms in dry eye diagnosis, treatment

Article

Recent research has created new perspectives on tear film dysfunction and ocular surface disease that is driving the development of new therapeutic concepts along with innovations in diagnosis and treatment.

Key Points

Orlando, FL-Recent research has created new perspectives on tear film dysfunction and ocular surface disease that is driving the development of new therapeutic concepts along with innovations in diagnosis and treatment, said Arthur B. Epstein, OD, at the annual meeting of the American Academy of Optometry.

He explained that the ocular surface and tear film can be thought of as a unique external environment created by the body. However, it is a complex microenvironment that consists of multiple components and that is continuously exposed to potentially disrupting factors within a macroenvironment.

Defects in the lipid, aqueous, and mucin components of the tear film can precipitate dry eye disease.

"Breakdown in the lipid, aqueous, or mucin components of the tear film can lead to dry eye, and the precipitating factor doesn't matter. Regardless of what that is, a perpetuating cyclic process is induced that leads to inflammation. Inflammation as a feature of dry eye disease develops as a last-ditch compensatory effort to fix a disrupted environment," he said.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.